XERS
Xeris Biopharma Holdings
$10.21
+$0.01 (+0.1%)Oct 26, 2026
Key metrics
The numbers that frame XERS today
- Market cap
- $1.86B
- EV / FCF
- 36.5
- Gross margin
- 86.6%
- EV / Sales
- 6.0
- ROIC
- 3.7%
- Div yield
- 0%
- 52wk Low
- $5.25
- 52wk High
- $11.42
Growth
Revenue and earnings trend for XERS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XERS
Is Xeris Biopharma Holdings a good buy?
Yes. Xeris Biopharma Holdings has strong quality and excellent momentum. Both signals support the setup. Growth looks mixed. The support signal is useful, but not decisive. We think Xeris Biopharma Holdings is selling at a fair price.
What is the market capitalization of XERS?
Xeris Biopharma Holdings's market capitalization is $1.86B.
What is the 52-week high for XERS stock?
The 52-week high for Xeris Biopharma Holdings is $11.42. The current close of $10.21 is 10.6% below that high.
What is the 52-week low for XERS stock?
The 52-week low for Xeris Biopharma Holdings is $5.25. The current close of $10.21 is 94.5% above that low.
Does XERS stock pay dividends?
Xeris Biopharma Holdings does not currently show a dividend per share in the company data.